Peter K. H. Lau

1.4k citations
41 papers · 675 indexed · h-index 14
Topics
Cancer Immunotherapy and Biomarkers (12 papers)CAR-T cell therapy research (10 papers)Melanoma and MAPK Pathways (9 papers)

In The Last Decade

Peter K. H. Lau

39 papers receiving 655 citations

Peers

Peter K. H. Lau
Comparison fields: 5 of 95
  • Oncology 374
  • Immunology 157
  • Molecular Biology 154
  • Pulmonary and Respiratory Medicine 151
  • Hematology 67
Replace Tian Tian with:
Tian Tian China
Lisa M. Kopp United States
Theo van den Broek Netherlands
Archie Bleyer United States
Anca Prica Canada
Richard D. Lopez United States
Lynn O’Donnell United States
Hye Sook Han South Korea
Iordanis Navrozoglou Greece
Jennifer Tseng United States
Peter K. H. Lau relative to Tian Tian China Tian Tian's profile →
Citations per field
00.5×1.5×
Tian Tian · 1×
Citations per year

Countries citing papers authored by Peter K. H. Lau

Since Specialization
Citations

This map shows the geographic impact of Peter K. H. Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K. H. Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K. H. Lau more than expected).

Fields of papers citing papers by Peter K. H. Lau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter K. H. Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K. H. Lau. The network helps show where Peter K. H. Lau may publish in the future.

Co-authorship network of co-authors of Peter K. H. Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Peter K. H. Lau. A scholar is included among the top collaborators of Peter K. H. Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter K. H. Lau. Peter K. H. Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 10
3 2
4 1
5 1
6 11
7 6
8 11
9 51
10 15
11 49
12 17
13 35
14 118
15 32
16 19
17 6
18 1
19 7
20 5

About Peter K. H. Lau

Peter K. H. Lau is a scholar working on Oncology, Hematology and Biochemistry, having authored 41 papers that have together received 675 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (10 papers) and Melanoma and MAPK Pathways (9 papers). The work is most often cited by research in Oncology (374 citations), Immunology (157 citations) and Hematology (67 citations). Peter K. H. Lau has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Grant A. McArthur, Sherene Loi, Amanda J. Oliver, Michael H. Kershaw, Clare Y. Slaney, Phillip K. Darcy, Georgia Soldatos, Jasna Aleksova, Shahneen Sandhu and Richard H. Aster. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026